Last reviewed · How we verify
NCT04860050: TURMEMIC
Turmeric for Memory Impairment and Cognition
NA trial testing Turmipure Gold® in Cognitive Change in 568 participants. Completed in 10 August 2023.
10 August 2023
Quick facts
| Lead sponsor | Givaudan France Naturals |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 568 |
| Start date | 19 April 2021 |
| Primary completion | 10 August 2023 |
| Estimated completion | 10 August 2023 |
| Sites | 1 location across Ireland |
Drugs / interventions tested
- Turmipure Gold®
- Placebo
Conditions studied
- Cognitive Change — all drugs for Cognitive Change →
- Mood — all drugs for Mood →
- Stress — all drugs for Stress →
Sponsor
Givaudan France Naturals
Who can join
Adults 60 to 85, any sex, with Cognitive Change or Mood. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the study is to test the capacity of acute and chronic supplementations of Turmipure GOLD® to improve cognitive performance in healthy aging
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04860050
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Turmipure Gold®
Trials testing the same drug.
- NCT04946981 — Recovery and Muscle Function After Supplementation With Turmeric · NA · completed
Other recruiting trials for Cognitive Change
Currently open trials in the same condition.
- NCT07147894 — Executive Function Training for Children and Adolescents · NA · recruiting
- NCT07383324 — Heat Stress in Individuals With Schizophrenia · NA · recruiting
- NCT07261202 — Impact of Indoor Overheating on Physiological Strain in Children · NA · recruiting
- NCT07267598 — Suitability of a 26 °C Indoor Environment for Mitigating Heat Strain in Young Adults · NA · recruiting
- NCT07054723 — Surviving Daily Life · recruiting
Other Givaudan France Naturals trials
Trials by the same sponsor.
- NCT05117385 — The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune) · NA · unknown
- NCT06300021 — Bioavailability of Curcuminoids From Turmipure Gold® in Different Food Matrices · NA · completed
- NCT04946981 — Recovery and Muscle Function After Supplementation With Turmeric · NA · completed
- NCT04506411 — Turmeric Efficacy for Mobility and Joint Function · NA · completed
- NCT04004013 — Evaluate the Effect of Lifenol in Improving Bone Status in Postmenopausal Osteopenic Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04860050 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Givaudan France Naturals
- Last refreshed: 18 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04860050.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing